T-lymphocyte perturbation following large-scale apheresis and hematopoietic stem cell transplantation in HIV-infected individuals

Analysis and mathematical modeling of T-lymphocyte perturbation following administration of granulocyte colony stimulating factor (G-CSF) and two large-scale aphereses are reported. 74 HIV-1 positive antiretroviral-treated individuals were infused with gene- or sham-transduced CD34+ hematopoietic st...

Full description

Saved in:
Bibliographic Details
Published inClinical immunology (Orlando, Fla.) Vol. 144; no. 2; pp. 159 - 171
Main Authors Savkovic, Borislav, Macpherson, Janet L., Zaunders, John, Kelleher, Anthony D., Knop, Alison E., Pond, Susan, Evans, Louise, Symonds, Geoff, Murray, John M.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Inc 01.08.2012
Elsevier
Subjects
HIV
PB
SSE
HIV
OZ1
LT
HSC
Online AccessGet full text
ISSN1521-6616
1521-7035
1521-7035
DOI10.1016/j.clim.2012.06.004

Cover

More Information
Summary:Analysis and mathematical modeling of T-lymphocyte perturbation following administration of granulocyte colony stimulating factor (G-CSF) and two large-scale aphereses are reported. 74 HIV-1 positive antiretroviral-treated individuals were infused with gene- or sham-transduced CD34+ hematopoietic stem cells (HSC) in a Phase II clinical trial. T cell numbers were examined in four phases: 1) during steady state; 2) increases in peripheral blood (PB) following G-CSF administration; 3) depletion post-aphereses and 4) reconstitution post HSC infusion. The present analysis provides the first direct estimate of CD4+ T cell distribution and trafficking in HIV-infected individuals on stable HAART, indicating that CD4+ T lymphocytes in PB represent 5.5% of the pool of CD4+ T lymphocytes that traffic to PB. ► We estimate T lymphocyte distribution and trafficking in HIV-infected subjects. ► We perform mathematical modeling on in-vivo T lymphocyte data. ► Our data is from a recent Phase II clinical trial of an anti-HIV gene therapy. ► We find that CD4+ T cells in peripheral blood represent 5.5% of total CD4+ T cells. ► We provide the first direct in-vivo estimate of T cell distribution during HIV.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1521-6616
1521-7035
1521-7035
DOI:10.1016/j.clim.2012.06.004